KRTAP9-1

Across TCGA pan-cancer cohorts, KRTAP9-1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated KRTAP9-1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher KRTAP9-1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRTAP9-1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and SCLC show a favorable association.

KIRC, LIHC, and KICH are the cancer types where KRTAP9-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.130	0.796	<.001	72	view →
LIHC	DFS	Tertile	II,III,IV	0.097	0.433	<.001	72	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
ESCA	DFS	Median	All	0.601	0.436	.012	38	view →
SCLC	DFS	Tertile	III,IV	0.785	0.467	.016	36	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	24	view →
THYM	OS	Tertile	All	0.704	0.987	.002	21	view →
LAML	DFS	Tertile	All	0.153	0.589	.019	18	view →
SKCM	DFS	Tertile	II,III,IV	0.212	0.564	.019	9	view →
UCEC	OS	Tertile	II,III,IV	0.716	0.860	.036	6	view →
COAD	OS	Tertile	IV	1.000	0.337	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

KRTAP9-1–KIRC (DFS)

Open the KIRC breakdown →